Shin Young-Soo, Chae Jin-Eon, Kang Tae-Wook, Han Seung-Beom
Department of Orthopedic Surgery, Veterans Health Service Medical Center, Seoul, South Korea.
Department of Orthopedic Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Injury. 2017 Jul;48(7):1550-1557. doi: 10.1016/j.injury.2017.04.011. Epub 2017 Apr 13.
Although both clinical and biomechanical studies suggest that cephalomedullary implants have a mechanical advantage over extramedullary implants, a high rate of complications or implant failure remains in elderly patients with osteoporosis. In an attempt to address some of these challenges, new implants with improved designs named proximal femoral nail antirotation II (PFNA II) and Zimmer natural nail (ZNN) were developed for elderly patients. Although the PFNA II reportedly has good clinical outcomes, it is unclear which implant achieves better safety and efficacy for treating intertrochanteric hip fractures. The primary objective of this prospective, randomized trial involved 353 patients was to evaluate Harris Hip Score (HHS). The secondary objective was to compare results associated with clinical outcome such as operation time, fluoroscopy time, lateral hip pain, walking ability, and reoperation rate as well as the incidence of cut-out by using implant position and fracture reduction quality.
353 patients with an intertrochanteric fracture amenable to either ZNN implant or PFNA II with a mean age of 77.0 years and a mean follow-up period of 12.3 months were included. We analyzed 353 patients with an intertrochanteric fracture treated using a ZNN implant (n=172, group I) or a PFNA II (n=181, group II) between January 2011 and August 2014.
There were no significant inter-group differences in HHS, walking ability, and reoperation rate were observed. However, operation and fluoroscopy time were significantly different between the two groups as well as group I showed a higher incidence of lateral hip pain than group II. In addition, no significant inter-group differences in cut-out rate determined by implant position and fracture reduction quality. We also found that cut-out was associated with lag screw position in the femoral head measured by Tip-apex distance (TAD) but not with reduction quality.
Although group I had significant longer operation and fluoroscopy time than group II, both implants are useful tools in the treatment of elderly intertrochanteric fractures as well as only TAD, but not Cleveland zone significantly correlated with lag screw cut-out.
尽管临床和生物力学研究均表明,髓内植入物相对于髓外植入物具有机械优势,但骨质疏松老年患者中并发症发生率或植入物失败率仍然很高。为应对其中一些挑战,针对老年患者开发了设计改进的新型植入物,即股骨近端抗旋髓内钉II(PFNA II)和齐默自然钉(ZNN)。尽管据报道PFNA II具有良好的临床效果,但尚不清楚哪种植入物在治疗股骨转子间骨折方面能实现更好的安全性和有效性。这项纳入353例患者的前瞻性随机试验的主要目的是评估Harris髋关节评分(HHS)。次要目的是比较与临床结局相关的结果,如手术时间、透视时间、髋关节外侧疼痛、行走能力、再手术率,以及通过植入物位置和骨折复位质量来比较切出发生率。
纳入353例适合使用ZNN植入物或PFNA II的股骨转子间骨折患者,平均年龄77.0岁,平均随访期12.3个月。我们分析了2011年1月至2014年8月期间使用ZNN植入物(n = 172,I组)或PFNA II(n = 181,II组)治疗的353例股骨转子间骨折患者。
HHS、行走能力和再手术率在组间未观察到显著差异。然而,两组之间的手术和透视时间存在显著差异,且I组髋关节外侧疼痛的发生率高于II组。此外,由植入物位置和骨折复位质量确定的切出率在组间无显著差异。我们还发现,切出与通过尖顶距(TAD)测量的股骨头拉力螺钉位置有关,而与复位质量无关。
尽管I组的手术和透视时间比II组显著更长,但两种植入物都是治疗老年股骨转子间骨折的有用工具,并且只有TAD与拉力螺钉切出显著相关,而克利夫兰分区与拉力螺钉切出无显著相关性。